Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPAREL vs Lidocaine in Pleuroscopy
NCT05044468Phase 2Active, not recruiting
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2021
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liposomal bupivacaine in malignant pleural neoplasm, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2021; status: active, not recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
malignant pleural neoplasm
Beyond the preview
Go deeper on NCT05044468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05044468.